Keyphrases
Multiparametric MRI (mpMRI)
100%
Imaging Marker
100%
Nigrostriatal System
100%
Parkinson's Disease
100%
Magnetic Resonance Imaging
32%
Substantia Nigra
32%
Disease-modifying Therapy
22%
Parkinson's Disease Progression
21%
Magnetic Resonance Imaging Data
21%
Body Fluids
21%
Parkinsonian Syndromes
21%
Imaging Biomarkers
21%
Disease-related
13%
Parkinson's Disease Diagnosis
12%
Physiological Processes
11%
Cell-Associated
11%
In Vivo Biomarkers
11%
Nigrostriatal Pathway
11%
Discovery Research
11%
Lack of Understanding
11%
Mechanistic Understanding
11%
Protein Profile
11%
Cell Loss
11%
Therapeutic Target
10%
Brain Analysis
10%
Fe Metabolism
10%
Existing Infrastructure
10%
Diffusion Tensor
10%
Pathological Process
10%
New Biomarkers
10%
Radioactivity
10%
Radioimaging
10%
Biochemical Changes
10%
Postmortem Brain
10%
Biosamples
10%
Pathophysiological Mechanisms
10%
Fractional Anisotropy
10%
Best Available Technologies
10%
Symptomatic Therapy
10%
Clinical Trials
10%
Brain Magnetic Resonance Imaging
10%
Correlation Data
10%
Single-photon Emission Computed Tomography (SPECT)
10%
New Therapeutics
10%
Basal Ganglia
10%
Meld
10%
Dopamine
10%
Lewy Bodies
10%
Clinical Population
10%
Neuronal Loss
10%
Power Analysis
10%
Striatal Dopamine
10%
123I
10%
Disease Biomarker
10%
Neuroscience
Magnetic Resonance Imaging
100%
Parkinson's Disease
100%
In Vivo
27%
Substantia nigra
26%
Positron Emission Tomography
17%
Parkinsonism
17%
Nigrostriatal Pathway
9%
Cell Loss
9%
Fractional Anisotropy
8%
Histopathology
8%
Basal Ganglia
8%
Iodine-123
8%
Radiography
8%
Lewy Body
8%
Single-Photon Emission Computed Tomography
8%
Iron Metabolism
8%
Biochemistry, Genetics and Molecular Biology
Magnetic Resonance Imaging
100%
Liquid
29%
Physiological Process
15%
Cell Loss
15%
Radioactivity
13%
Single Photon Emission Computed Tomography
13%
Fractional Anisotropy
13%
Iodine-123
13%
Iron Metabolism
13%
Facilitated Diffusion
13%
Clinical Trial
13%